Translational Lung Cancer Research

Translational Lung Cancer Research

转化肺癌研究

  • 3区 中科院分区
  • Q2 JCR分区

期刊简介

《Translational Lung Cancer Research》是由Society for Translational Medicine (STM)出版社于2012年创办的英文国际期刊(ISSN: 2218-6751,E-ISSN: 2226-4477),该期刊长期致力于肿瘤学领域的创新研究,主要研究方向为Medicine-Oncology。作为SCI、SCIE收录期刊(JCR分区 Q2,中科院 3区),本刊采用OA开放获取模式(OA占比0.8259...%),以发表肿瘤学领域等方向的原创性研究为核心(研究类文章占比84.21%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在380篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Translational Lung Cancer Research审稿周期约为In-house review: 1-3 weeks。该刊近年未被列入国际预警名单,年发文量约380篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 380 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
3区 3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
3区 3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
3区 3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
RESPIRATORY SYSTEM 呼吸系统 ONCOLOGY 肿瘤学
3区 4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
ONCOLOGY 肿瘤学 RESPIRATORY SYSTEM 呼吸系统
2区 2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 148 / 333

55.7

学科:RESPIRATORY SYSTEM SCIE Q2 36 / 107

66.8

学科:ONCOLOGY SCIE Q2 129 / 333

61.41

学科:RESPIRATORY SYSTEM SCIE Q2 40 / 107

63.08

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:ONCOLOGY SCIE Q2 95 / 322

70.7

学科:RESPIRATORY SYSTEM SCIE Q1 22 / 100

78.5

学科:ONCOLOGY SCIE Q2 102 / 322

68.48

学科:RESPIRATORY SYSTEM SCIE Q2 34 / 101

66.83

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:4.6 SJR:0.987 SNIP:0.891
学科类别 分区 排名 百分位
大类:Medicine 小类:Oncology Q2 183 / 428

57%

期刊发文

  • Development of a deep learning model based on computed tomography automatic segmentation to assist in selecting optimal time-to-surgery and dissected lymph node count for non-small cell lung cancer patients undergoing neoadjuvant immunotherapy and chemotherapy: a multicenter stud

    Author: Zhao, Junfeng; Li, Ying; Chen, Jiaxuan; Han, Chuankun; Yan, Yifei; Zhou, Chen; Bai, Yingrui; Xu, Yali; Li, Yintao

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-1-1495

  • Prognostic implications of dominant lesion misidentification in multiple primary lung cance

    Author: Zhao, Bowen; Su, Xiaoyun; Huang, Yu; Han, Xiaoyu; Li, Yan; Zhang, Chi; Gen, Zuhan; Len, Qiuyu; He, Shiwen; Fan, Shiwen; Chen, Ming; Li, Kuo; Yang, Fan; Wu, Guangyao; Liao, Yongde

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-aw-1316

  • Adjuvant chemotherapy for completely resected stage IB-IIA non-small cell lung cancer according to the AJCC 8th edition staging system: a real-world retrospective cohort study based on the SEER databas

    Author: Sun, Zewen; Zhao, Changtai; Feng, Kexin; Chang, Geyun; Zhang, Jingwei; Ju, Yan; Yang, Fan; Yan, Xiang; Li, Xiao

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-1-1403

  • Development and validation of a habitat-based computed tomography radiomics model for differentiating isolated lung cancer, isolated tuberculoma, and coexistence of tuberculosis with lung cancer: a dual-center retrospective stud

    Author: Shi, Ning; Wan, Zhenzhen; Wen, Limin; Liu, Zhenpeng; Wang, Bing; Li, Ye; Xiong, Peng; Hou, Dailun; Liu, Xiuling

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-1-1381

  • A radiomics nomogram integrated with radiological features for preoperative prediction of lung nodule invasiveness: comparison with Lung-BAD

    Author: Miao, Siwei; Han, Zhaojie; Wang, Fei; Liu, Shengwei; Li, Ying; Li, Kun; Wang, Hongqian; Gao, Shuaixiang; Xiong, Xiaolin; Luo, Hao; Huang, Chencui; Qiu, Yang; Wang, Peng; Wang, Haidong

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-1083

  • Integrated management of immunotherapy and radiotherapy for patients with metastatic non-small cell lung cancer: a narrative review of current landscape and future direction

    Author: Liang, Xinquan; Li, Fengxue; Zhang, Yingying; Hu, Pingping; Tian, Tiantian; Zhang, Yan; Liang, Ning; Deng, Guodong; Ding, Fangjie; Liu, Xin; Qiao, Lili; Zhang, Jiandong

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2026-1-0018

  • B cell-driven refractory hemocytopenia in immune checkpoint inhibitor therapy: a report of two case

    Author: Li, Feng; Wang, Chunyan; Yao, Guohua; Zhang, Shaotong; Hu, Qian; Ju, Zhenyu; Liang, Wenhua

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-939

  • Lightweight hybrid foundation model for lung cancer prognosis based on low-dose chest X-ray image

    Author: Hayeso, Helen Haile; Lonseko, Zenebe Markos; Alotaibi, Fahad Mushabbab G.; Gan, Tao; Shi, Peifeng; Dong, Shuqi; Rao, Nini

    Journal: TRANSLATIONAL LUNG CANCER RESEARCH. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.21037/tlcr-2025-aw-1299